EMKELOS Trademark

Trademark Overview

On Monday, June 5, 2017, a trademark application was filed for EMKELOS with the United States Patent and Trademark Office. The USPTO has given the EMKELOS trademark a serial number of 87475255. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 28, 2021. This trademark is owned by Bristol-Myers Squibb Company. The EMKELOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
emkelos

General Information

Serial Number87475255
Word MarkEMKELOS
Filing DateMonday, June 5, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, June 28, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 28, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020EXTENSION 5 GRANTED
Wednesday, November 11, 2020EXTENSION 5 FILED
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Friday, May 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020EXTENSION 4 GRANTED
Wednesday, May 13, 2020EXTENSION 4 FILED
Wednesday, May 13, 2020TEAS EXTENSION RECEIVED
Friday, November 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2019EXTENSION 3 GRANTED
Wednesday, November 20, 2019EXTENSION 3 FILED
Wednesday, November 20, 2019TEAS EXTENSION RECEIVED
Wednesday, May 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2019EXTENSION 2 GRANTED
Monday, May 6, 2019EXTENSION 2 FILED
Monday, May 6, 2019TEAS EXTENSION RECEIVED
Thursday, November 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 13, 2018EXTENSION 1 GRANTED
Tuesday, November 13, 2018EXTENSION 1 FILED
Tuesday, November 13, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 22, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 17, 2017NON-FINAL ACTION E-MAILED
Thursday, August 17, 2017NON-FINAL ACTION WRITTEN
Thursday, August 10, 2017ASSIGNED TO EXAMINER
Saturday, June 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 8, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

emkelos diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection